Frequency and Treatment-Related Predictors of Thymidine-Analogue Mutation Patterns in HIV-1 Isolates after Unsuccessful Antiretroviral Therapy

De Luca, Andrea; Di Giambenedetto, Simona; Romano, Laura; Gonnelli, Angela; Corsi, Paola; Baldari, Marco; Di Pietro, Massimo; Menzo, Stefano; Francisci, Daniela; Almi, Paolo; Zazzi, Maurizio
May 2006
Journal of Infectious Diseases;5/1/2006, Vol. 193 Issue 9, p1219
Academic Journal
We investigated, in patients tested between 1991 and 2004, the patterns of mutually exclusive human immunodeficiency virus-1 thymidine-analogue mutations (TAMs) in 4039 reverse-transcriptase sequences with ⩾1 TAM. TAM pattern 1, which included M41L and L210W and excluded K70R and is coupled with more-extensive cross-resistance to drugs, became the most frequent pattern after 1996. In 1465 genotypes from 684 patients in whom highly active antiretroviral therapy (HAART) was unsuccessful, predictors of this pattern were the number of previous HAART regimens undergone (adjusted odds ratio [OR], 1.09 [95% confidence interval {CI}, 1.02-1.16]), use of stavudine/lamivudine (adjusted OR, 1.42 [95% CI, 1.05-1.99]), use of nevirapine (adjusted OR, 1.60 [95% CI, 1.14-2.24]), use of efavirenz (adjusted OR, 1.56 [95% CI, 1.08-2.27]), and use of ritonavir (adjusted OR, 1.35 [95% CI, 1.04-1.75]).


Related Articles

  • Synonymous Genetic Polymorphisms within Brazilian Human Immunodeficiency Virus Type 1 Subtypes May Influence Mutational Routes to Drug Resistance. Dumans, Ana T.; Soares, Marcelo A.; Machado, Elizabeth S.; Hué, Stéphane; Brindeiro, Rodrigo M.; Pillay, Deenan; Tanuri, Amilcar // Journal of Infectious Diseases;4/1/2004, Vol. 189 Issue 7, p1232 

    Most published data on antiretroviral-drug resistance is generated from in vitro or in vivo studies of subtype B virus. However, this subtype is associated with <10% of HIV infections worldwide, and it is essential to explore subtype-specific determinants of drug resistance. One potential cause...

  • Antiretroviral Recommendations May Influence the Rate of Transmission of Drug-Resistant HIV Type 1. de Mendoza, Carmen; Rodriguez, Carmen; Eiros, José Maria; Colomina, Javier; Garcia, Federico; Leiva, Pilar; Torre-Cisneros, Julián; Aguero, Jesús; Pedreira, José; Viciana, Isabel; Corral, Angé lica; del Romero, Jorge; de Lejarazu, Raú l Ortiz; Soriano, Vincent // Clinical Infectious Diseases;7/15/2005, Vol. 41 Issue 2, p227 

    Background. Human immunodeficiency virus (HIV) treatment guidelines have evolved, shifting from more- aggressive to more-conservative approaches. The potential impact of these shifts on the transmission of drug- resistant virus is unknown. Methods. Drug-resistance genotypes were examined in all...

  • A Review of HIV-1 Resistance to the Nucleoside and Nucleotide Inhibitors. Shulman, Nancy; Winters, Mark // Current Drug Targets - Infectious Disorders;Dec2003, Vol. 3 Issue 4, p273 

    The nucleoside reverse transcriptase inhibitors (NRTIs) were the first class of agents used for the treatment of HIV and remain an important component of combination antiretroviral therapy. Resistance to the NRTIs occurs by the acquisition of mutations in the reverse transcriptase gene that...

  • Virological efficacy and immunological recovery among Ethiopian HIV-1 infected adults and children. Mulu, Andargachew; Gerd Liebert, Uwe; Maier, Melanie // BMC Infectious Diseases;2014, Vol. 14 Issue 1, p1 

    Background Introduction of antiretroviral therapy (ART) in sub-Saharan Africa was a hot debate due to many concerns about adherence, logistics and resistance. Currently, it has been significantly scaled up. However as the WHO clinico-immunological approaches for initiation and monitoring of ART...

  • In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species. Thompson, George R.; Wiederhold, Nathan P.; Sutton, Deanna A.; Fothergill, Annette; Patterson, Thomas F. // Journal of Antimicrobial Chemotherapy (JAC);Jul2009, Vol. 64 Issue 1, p79 

    Objectives The emergence of less common, but clinically important, fungal pathogens including the rare yeasts has contributed to the substantial morbidity and mortality observed in immunocompromised patients. These organisms can be resistant or refractory to existing antifungal agents. We sought...

  • Assessing Resistance Costs of Antiretroviral Therapies via Measures of Future Drug Options. Hongyu Jiang, Elisabeth E.; Deeks, Steven G.; Kuritzkes, Daniel R.; Lallemant, Marc; Katzenstein, David; Albrecht, Mary; DeGruttola, Victor // Journal of Infectious Diseases;10/1/2003, Vol. 188 Issue 7, p1001 

    Assesses resistance costs of antiretroviral therapies via measures of future drug options. Indication tha tthe regimen with the highest virologic failure rate preserved greater future drug options; Outcome of antiretroviral therapy trials which may complement traditional clinical, virologic and...

  • Response of Feline Immunodeficiency Virus (FIV) to Tipranavir May Provide New Clues for Development of Broad-Based Inhibitors of Retroviral Proteases Acting on Drug-Resistant HIV-1. Norelli, Sandro; El Daker, Sary; D'Ostilio, Daniela; Mele, Federico; Mancini, Fabiola; Taglia, Fabiana; Ruggieri, Anna; Ciccozzi, Massimo; Cauda, Roberto; Ciervo, Alessandra; Barreca, Maria L.; Pistello, Mauro; Bendinelli, Mauro; Savarino, Andrea // Current HIV Research;Jul2008, Vol. 6 Issue 4, p306 

    The feline AIDS model for HIV-1 treatment failed in the 1990s, due to structural features resembling protease inhibitor (PI) resistant HIV-1 variants. Widespread drug-resistance to PIs now invokes the possibility of rescuing feline immunodeficiency virus (FIV) as a model for PI treatment. We...

  • Extensively Drug-Resistant Tuberculosis: Are We Learning from History or Repeating It? Extensively Drug-Resistant Tuberculosis: Are We Learning from History or Repeating It? Hamilton, Carol Dukes; Sterling, Timothy R.; Blumberg, Henry M.; Leonard, Michael; McAuley, James; Schlossberg, David; Stout, Jason; Huitt, Gwen // Clinical Infectious Diseases;8/1/2007, Vol. 45 Issue 3, p338 

    Tuberculosis (TB) is an enormous global public health problem. Cases of extensively drug-resistant TB (XDR-TB) are being reported in increasing numbers across the globe. A large outbreak of XDR-TB associated with rapid and nearly universal mortality has been reported among patients with human...

  • HIV-1 Reverse Transcriptase: A Therapeutical Target in the Spotlight. Castro, H. C.; Loureiro, N. I.V.; Pujol-Luz, M.; Souza, A. M.T.; Albuquerque, M. G.; Santos, D. O.; Cabral, L. M.; Frugulhetti, I. C.; Rodrigues, C. R. // Current Medicinal Chemistry;2006, Vol. 13 Issue 3, p313 

    Human Immunodeficiency Virus type 1 Reverse Transcriptase (HIV-1 RT) is one of the most important targets for treatment of Acquired Immune Deficiency Syndrome (AIDS). It catalyzes the reverse transcription of HIV-RNA into a double stranded DNA, and the knowledge of its substrate specificity and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics